Endocrine Abstracts

JOINT1280

Long-acting growth hormone (LAGH) is a treatment given to children with growth hormone deficiency. Adherence and concordance with treatment is essential for children to reach their height potential, but it is not always optimal. Several patient needs have been identified that may support with adherence and concordance. These include maintaining an injection routine, having access to answers of treatment-related questions and tracking progress over time, such as height gain. The use of a LAGH digital connected system with these features may aid in adherence and concordance to treatment. MySoConnect® for Sogroya® (somapacitan; Novo Nordisk Health Care AG) was developed to improve the patient experience and aid in adherence and concordance with growth hormone (GH) treatment (GHT). The system consists of a Sogroya® FlexPro® injection pen, the Mallya® connectivity cap and the MySoConnect® app. The Mallya® cap connects with the MySoConnect® app when attached to the Sogroya® FlexPro® injection pen and aligned with the dose counter of the pen. The Mallya® connectivity cap is compatible with all three available strengths of the Sogroya® FlexPro® injection pen. The MySoConnect® app includes features that can support in setting an injection routine, such as setting a dose reminder, which can be performed manually within the app. Features related to dose management, such as dose, dosing day and type of injection pen used, are recorded. The MySoConnect® app also includes a training and support section, which provides useful information related to understanding treatment, tailored towards patients and their caregivers. Additionally, the app includes the option to manually input height and weight data to allow visualisation of height and weight improvements over time. Lastly, the app allows users to download a log of dosing patterns, which can be shared with their healthcare professional to advise on dosing changes. MySoConnect® for Sogroya® was developed to improve the user experience for children prescribed Sogroya® and their caregivers. This connected system will allow its users to set and maintain an injection routine, have continuous access to training and support related to GHT, and record and track various elements of their treatment journey over time. MySoConnect® for Sogroya® may support its users in maintaining adherence.